Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mersana Therapeutics Inc (MRSN)

Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mersana Therapeutics Inc 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 USA

www.mersana.com Employees: 123 P: 617-498-0020

Description:

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

Key Statistics

Overview:

Market Capitalization, $K 225,722
Enterprise Value, $K 76,392
Shares Outstanding, K 122,675
Annual Sales, $ 36,860 K
Annual Net Income, $ -171,670 K
Last Quarter Sales, $ 2,290 K
Last Quarter Net Income, $ -24,270 K
EBIT, $ -111,830 K
EBITDA, $ -114,880 K
60-Month Beta 1.50
% of Insider Shareholders 11.80%
% of Institutional Shareholders 93.92%
Float, K 108,199
% Float 88.20%
Short Volume Ratio 0.28

Growth:

1-Year Return 30.28%
3-Year Return -79.87%
5-Year Return -32.85%
5-Year Revenue Growth 248.06%
5-Year Earnings Growth 46.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 08/13/24
Next Earnings Date 11/05/24 [--]
Earnings Per Share ttm -0.87
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year 57.45%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MRSN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -333.91%
Return-on-Assets % -48.37%
Profit Margin % -465.74%
Debt/Equity 3.01
Price/Sales 6.06
Price/Cash Flow N/A
Price/Book 26.43
Book Value/Share 0.07
Interest Coverage -41.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar